Found: 8
Select item for more details and to access through your institution.
Trends in molecular subtypes of breast cancer: description of incidence rates between 2007 and 2012 from three French registries.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Fluorouracil, leucovorin and irinotecan associated with aflibercept can induce microscopic colitis in metastatic colorectal cancer patients.
- Published in:
- Investigational New Drugs, 2015, v. 33, n. 6, p. 1263, doi. 10.1007/s10637-015-0295-6
- By:
- Publication type:
- Article
Respective contribution of baseline clinical data, tumour metabolism and tumour blood-flow in predicting pCR after neoadjuvant chemotherapy in HER2 and Triple Negative breast cancer.
- Published in:
- EJNMMI Research, 2024, v. 14, n. 1, p. 1, doi. 10.1186/s13550-024-01115-4
- By:
- Publication type:
- Article
HER2-Low Luminal Breast Carcinoma Is Not a Homogenous Clinicopathological and Molecular Entity.
- Published in:
- Cancers, 2024, v. 16, n. 11, p. 2009, doi. 10.3390/cancers16112009
- By:
- Publication type:
- Article
Custom multi-tumor next-generation sequencing panel for routine molecular diagnosis of solid tumors: Validation and results from three-year clinical use.
- Published in:
- International Journal of Molecular Medicine, 2022, v. 49, n. 5, p. N.PAG, doi. 10.3892/ijmm.2022.5113
- By:
- Publication type:
- Article
ER−/PR+ breast cancer: A distinct entity, which is morphologically and molecularly close to triple‐negative breast cancer.
- Published in:
- International Journal of Cancer, 2021, v. 149, n. 1, p. 200, doi. 10.1002/ijc.33539
- By:
- Publication type:
- Article
Anticipating changes in the HER2 status of breast tumours with disease progression—towards better treatment decisions in the new era of HER2-low breast cancers.
- Published in:
- British Journal of Cancer, 2023, v. 129, n. 1, p. 122, doi. 10.1038/s41416-023-02287-x
- By:
- Publication type:
- Article
HER2-positive invasive lobular carcinoma: a rare breast cancer which may not necessarily require anti-HER2 therapy. A population-based study.
- Published in:
- Breast Cancer (13406868), 2023, v. 30, n. 3, p. 343, doi. 10.1007/s12282-022-01432-3
- By:
- Publication type:
- Article